Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.

NCT06600022 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumours

Interventions

DRUG: SCTB41

Sponsor

Sinocelltech Ltd.